Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

S-equol supplements significantly reduced menopausal symptoms in most women.

Aromatase inhibitors can cause various adverse reactions, so monitoring is crucial.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

5-alpha reductase inhibitors do not increase hip fracture risk.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Dutasteride is more effective for male pattern baldness than finasteride, and black cohosh extract BNO 1055 is as effective as conjugated estrogens in treating postmenopausal symptoms, with added benefits in reducing sweating and mental symptoms.

Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.

Cryptotanshinone may help treat postmenopausal osteoporosis and protect kidneys.

Finasteride at 1 mg daily doesn't help hair loss in postmenopausal women and has similar side effects to a placebo.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

A new method effectively predicts estrogen-related health effects for early screening.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

The rs1128977 gene variant may affect cholesterol and body measurements.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

CL22209, an Asparagus racemosus extract, safely reduces perimenopausal symptoms and balances hormones.